Habiger David C has filed 50 Form 4 transactions across five companies, with a total buy value of $407,921.56 and zero sell value. The pattern is heavily skewed toward acquisition, not disposition. Open-market purchases appear only in Boston Scientific (BSX), where Habiger made four buys between May and August 2026. The largest was $125,818.88 on May 20, followed by $99,936.90 on August 5, $50,084.25 on August 3, and a smaller $6,802.31 on August 4. Combined, those BSX purchases account for roughly $282,642 of the total buy figure.
The rest of the activity is compensation-related. Grants (code A) dominate the recent filings, particularly in EnerSys (ENS), where Habiger received multiple awards on October 15, October 2, July 16, and July 2, 2026, most with zero dollar value but two valued at $29,379.40 and $27,927.90. Similar grants appear in Reddit (RDDT) on October 5, July 5, and June 8, and in LFTO on August 4, valued at $234,998.12. The total acquired value across all filings is $400,585.69, nearly matching the buy total, which suggests the bulk of Habiger's reported value comes from grants rather than discretionary purchases.
The recent direction is clear: four buys in the last reporting window, zero sells. Habiger has not filed a single open-market sale (code S) or issuer buyback (code D) in the data. The BSX purchases are the only cash transactions, and they cluster in a three-day span in early August plus a single May buy. That concentration, alongside the steady stream of ENS grants, points to a holder adding to one position while receiving equity awards elsewhere, with no indication of trimming any stake.
AI-assisted summary